Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer

Autor: C Ramsay, R Pickard, C Robertson, A Close, L Vale, N Armstrong, DA Barocas, CG Eden, C Fraser, T Gurung, D Jenkinson, X Jia, TB Lam, G Mowatt, DE Neal, MC Robinson, J Royle, SP Rushton, P Sharma, MDF Shirley, N Soomro

Publikováno v: Health Technology Assessment, Vol 16, Iss 41 (2012)

Background: Complete surgical removal of the prostate, radical prostatectomy, is the most frequently used treatment option for men with localised prostate cancer. The use of laparoscopic (keyhole) and robot-assisted surgery has improved operative saf

Externí odkaz: https://doaj.org/article/060fdf23bd44474f93115414f8738080

Recurrence pattern in localized RCC: results from a European multicenter database (RECUR).

Autor: Fallara G; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy., Larcher A; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy., Dabestani S; Department of Translational Medicine, Division of Urological Cancers, Kristianstad Central Hospital, Lund University, Lund, Sweden., Fossati N; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy., Järvinen P; Abdominal Center, Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Nisen H; Abdominal Center, Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Gudmundsson E; Department of Urology, Landspitali University Hospital, Reykjavik, Iceland., Lam TB; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Marconi L; Department of Urology, Coimbra University Hospital, Coimbra, Portugal., Fernandéz-Pello S; Department of Urology, Cabueñes University Hospital, Gijón, Spain., Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands., Volpe A; Department of Urology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy., Beisland C; Department of Urology, Haukeland University Hospital, Norway and Department of Clinical Medicine, University of Bergen, Bergen, Norway., Klatte T; Department of Surgery, University of Cambridge, Cambridge, UK; Department of Urology, The Royal Bournemouth Hospital, University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK., Stewart GD; Department of Surgery, University of Cambridge, Cambridge, UK., Bensalah K; Department of Urology, University of Rennes, Rennes, France., Ljungberg B; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden., Bertini R; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy., Montorsi F; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy., Bex A; Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, UCL Division of Surgical and Interventional Science, London, UK; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Capitanio U; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy. Electronic address: capitanio.umberto@hsr.it.

Publikováno v: Urologic oncology [Urol Oncol] 2022 Nov; Vol. 40 (11), pp. 494.e11-494.e17. Date of Electronic Publication: 2022 Sep 17.

Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Autor: Lardas M; Department of Urology, Metropolitan General Hospital, Athens, Greece. Electronic address: lardamk@gmail.com., Grivas N; Department of Urology, University General Hospital of Heraklion, University of Crete Medical School, Heraklion, Greece., Debray TPA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Zattoni F; Urology Unit, Santa Maria della Misericordia University Hospital, Udine, Italy., Berridge C; Worcestershire Acute Hospitals NHS Trust, Redditch, UK., Cumberbatch M; Academic Urology Unit, University of Sheffield, Sheffield, UK., Van den Broeck T; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Briers E; Patient Advocate, Hasselt, Belgium., De Santis M; Department of Urology, Charité Universitätsmedizin Berlin, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria., Farolfi A; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy., Fossati N; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Gandaglia G; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Gillessen S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland., O'Hanlon S; Medicine for Older People, Saint Vincent's University Hospital, Dublin, Ireland., Henry A; Leeds Cancer Centre, St. James's University Hospital and University of Leeds, Leeds, UK., Liew M; Department of Urology, Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, Wigan, UK., Mason M; Division of Cancer & Genetics, Cardiff University School of Medicine, Velindre Cancer Centre, Cardiff, UK., Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Oprea-Lager D; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Ploussard G; La Croix du Sud Hospital, Quint Fonsegrives, France., Rouviere O; Department of Urinary and Vascular Imaging, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France., Schoots IG; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Kwast T; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Poel H; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany., Willemse PP; Department of Oncological Urology, University Medical Center, Utrecht Cancer Center, Utrecht, The Netherlands., Yuan CY; Department of Medicine, Health Science Centre, McMaster University, Hamilton, ON, Canada., Grummet JP; Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia., Tilki D; Martini-Klinik Prostate Cancer Center, and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., van den Bergh RCN; Department of Urology, Antonius Hospital, Utrecht, The Netherlands., Lam TB; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Cornford P; Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK., Mottet N; Department of Urology, University Hospital, St. Etienne, France.

Publikováno v: European urology focus [Eur Urol Focus] 2022 May; Vol. 8 (3), pp. 674-689. Date of Electronic Publication: 2021 May 06.

Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT.

Autor: Dasgupta R; Department of Urology, Imperial College Healthcare NHS Trust, London, UK., Cameron S; Centre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK., Aucott L; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., MacLennan G; Centre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK., Kilonzo MM; Health Economics Research Unit, University of Aberdeen, Aberdeen, UK., Lam TB; NHS Grampian, Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Thomas R; Centre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK., Norrie J; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK., McDonald A; Centre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK., Anson K; Department of Urology, St George's University Hospitals NHS Foundation Trust, London, UK., N'Dow J; NHS Grampian, Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Burgess N; Department of Urology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Clark CT; Stone Patient Advisory Group, Section of Endourology, British Association of Urological Surgeons, London, UK., Keeley FX; Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK., MacLennan SJ; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Starr K; Centre for Healthcare Randomised Trials, University of Aberdeen, Aberdeen, UK., McClinton S; NHS Grampian, Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.

Publikováno v: Health technology assessment (Winchester, England) [Health Technol Assess] 2022 Mar; Vol. 26 (19), pp. 1-70.

The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care.

Autor: Bedke J; Department of Urology, University Hospital Tübingen, Tuebingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Albiges L; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Capitanio U; Department of Urology, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology/Unit of Urology, URI, IRCCS San Raffaele Hospital, Milan, Italy., Giles RH; International Kidney Cancer Coalition (IKCC), Duivendrecht, The Netherlands., Hora M; Department of Urology, University Hospital Pilsen and Faculty of Medicine in Pilsen, Charles University, Czech Republic., Lam TB; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Ljungberg B; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Marconi L; Department of Urology, Coimbra University Hospital, Coimbra, Portugal., Klatte T; Department of Urology, Royal Bournemouth Hospital, Bournemouth, UK; Department of Surgery, University of Cambridge, Cambridge, UK., Volpe A; Department of Urology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy., Abu-Ghanem Y; Department of Urology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel., Dabestani S; Department of Translational Medicine, Division of Urological Cancers, Lund University, Malmö, Sweden., Pello SF; Department of Urology, Cabueñes University Hospital, Gijón, Spain., Hofmann F; Department of Urology, Sunderby Sjukhus, Umeå University, Luleå, Sweden., Kuusk T; Department of Urology, Darent Valley Hospital, Dartford and Gravesham NHS Trust, Dartford, UK., Tahbaz R; Department of Urology, Charité University Hospital Berlin, Germany., Powles T; The Royal Free NHS Trust and Barts Cancer Institute, Queen Mary University of London, London, UK., Bex A; The Royal Free London NHS Foundation Trust, London, UK; UCL Division of Surgery and Interventional Science, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: a.bex@ucl.ac.uk.

Publikováno v: European urology [Eur Urol] 2021 Oct; Vol. 80 (4), pp. 393-397. Date of Electronic Publication: 2021 May 29.